Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis

Yuichi Morohoshi, Katsuyoshi Matsuoka, Hiroshi Chinen, Nobuhiko Kamada, Toshiro Sato, Tadakazu Hisamatsu, Susumu Okamoto, Nagamu Inoue, Hiromasa Takaishi, Haruhiko Ogata, Yasushi Iwao, Toshifumi Hibi

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: Neutrophil elastase (NE) is a major secretory product from activated neutrophils and a major contributor to tissue destruction. However, little is known about the pathogenic contribution of NE to ulcerative colitis (UC). This study was designed to investigate the contribution of NE by measuring NE activity in plasma and colonic mucosal tissue from UC patients and a murine acute colitis model, and to elucidate the therapeutic effect of the NE-specific inhibitor ONO-5046. Methods: The NE enzyme activities in plasma and colonic mucosal tissue from UC patients were directly measured using an enzyme-substrate reaction. Acute colitis was induced in mice by administration of 1.5% dextran sulfate sodium (DSS) for 5 days. DSS-induced colitis mice were then treated with ONO-5046 (50 mg/kg body weight) intraperitoneally twice a day. Results: In UC patients, the NE enzyme activity was significantly elevated in both the plasma and colonic mucosal tissue compared with healthy controls. In DSS-induced colitis mice, the NE enzyme activity increased in parallel with the disease development. ONO-5046 showed therapeutic effects in DSS-treated mice by significantly reducing weight loss and histological score. ONO-5046 suppressed the NE enzyme activities in both plasma and culture supernatant of colonic mucosa from DSS-induced colitis mice. Conclusions: ONO-5046, a specific NE inhibitor, prevented the development of DSS-induced colitis in mice. NE therefore represents a promising target for the treatment of UC patients.

Original languageEnglish
Pages (from-to)318-324
Number of pages7
JournalJournal of Gastroenterology
Volume41
Issue number4
DOIs
Publication statusPublished - 2006 Apr

Fingerprint

Leukocyte Elastase
Dextran Sulfate
Colitis
Ulcerative Colitis
Mucous Membrane
Secretory Proteinase Inhibitory Proteins
Enzymes
Therapeutic Uses
Weight Loss
Neutrophils
Body Weight
sivelestat

Keywords

  • Dextran sulfate sodium-induced colitis
  • Neutrophil elastase
  • ONO-5046
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. / Morohoshi, Yuichi; Matsuoka, Katsuyoshi; Chinen, Hiroshi; Kamada, Nobuhiko; Sato, Toshiro; Hisamatsu, Tadakazu; Okamoto, Susumu; Inoue, Nagamu; Takaishi, Hiromasa; Ogata, Haruhiko; Iwao, Yasushi; Hibi, Toshifumi.

In: Journal of Gastroenterology, Vol. 41, No. 4, 04.2006, p. 318-324.

Research output: Contribution to journalArticle

Morohoshi, Yuichi ; Matsuoka, Katsuyoshi ; Chinen, Hiroshi ; Kamada, Nobuhiko ; Sato, Toshiro ; Hisamatsu, Tadakazu ; Okamoto, Susumu ; Inoue, Nagamu ; Takaishi, Hiromasa ; Ogata, Haruhiko ; Iwao, Yasushi ; Hibi, Toshifumi. / Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. In: Journal of Gastroenterology. 2006 ; Vol. 41, No. 4. pp. 318-324.
@article{7f4c682d991d42bba48cf6d94107ea87,
title = "Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis",
abstract = "Background: Neutrophil elastase (NE) is a major secretory product from activated neutrophils and a major contributor to tissue destruction. However, little is known about the pathogenic contribution of NE to ulcerative colitis (UC). This study was designed to investigate the contribution of NE by measuring NE activity in plasma and colonic mucosal tissue from UC patients and a murine acute colitis model, and to elucidate the therapeutic effect of the NE-specific inhibitor ONO-5046. Methods: The NE enzyme activities in plasma and colonic mucosal tissue from UC patients were directly measured using an enzyme-substrate reaction. Acute colitis was induced in mice by administration of 1.5{\%} dextran sulfate sodium (DSS) for 5 days. DSS-induced colitis mice were then treated with ONO-5046 (50 mg/kg body weight) intraperitoneally twice a day. Results: In UC patients, the NE enzyme activity was significantly elevated in both the plasma and colonic mucosal tissue compared with healthy controls. In DSS-induced colitis mice, the NE enzyme activity increased in parallel with the disease development. ONO-5046 showed therapeutic effects in DSS-treated mice by significantly reducing weight loss and histological score. ONO-5046 suppressed the NE enzyme activities in both plasma and culture supernatant of colonic mucosa from DSS-induced colitis mice. Conclusions: ONO-5046, a specific NE inhibitor, prevented the development of DSS-induced colitis in mice. NE therefore represents a promising target for the treatment of UC patients.",
keywords = "Dextran sulfate sodium-induced colitis, Neutrophil elastase, ONO-5046, Ulcerative colitis",
author = "Yuichi Morohoshi and Katsuyoshi Matsuoka and Hiroshi Chinen and Nobuhiko Kamada and Toshiro Sato and Tadakazu Hisamatsu and Susumu Okamoto and Nagamu Inoue and Hiromasa Takaishi and Haruhiko Ogata and Yasushi Iwao and Toshifumi Hibi",
year = "2006",
month = "4",
doi = "10.1007/s00535-005-1768-8",
language = "English",
volume = "41",
pages = "318--324",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis

AU - Morohoshi, Yuichi

AU - Matsuoka, Katsuyoshi

AU - Chinen, Hiroshi

AU - Kamada, Nobuhiko

AU - Sato, Toshiro

AU - Hisamatsu, Tadakazu

AU - Okamoto, Susumu

AU - Inoue, Nagamu

AU - Takaishi, Hiromasa

AU - Ogata, Haruhiko

AU - Iwao, Yasushi

AU - Hibi, Toshifumi

PY - 2006/4

Y1 - 2006/4

N2 - Background: Neutrophil elastase (NE) is a major secretory product from activated neutrophils and a major contributor to tissue destruction. However, little is known about the pathogenic contribution of NE to ulcerative colitis (UC). This study was designed to investigate the contribution of NE by measuring NE activity in plasma and colonic mucosal tissue from UC patients and a murine acute colitis model, and to elucidate the therapeutic effect of the NE-specific inhibitor ONO-5046. Methods: The NE enzyme activities in plasma and colonic mucosal tissue from UC patients were directly measured using an enzyme-substrate reaction. Acute colitis was induced in mice by administration of 1.5% dextran sulfate sodium (DSS) for 5 days. DSS-induced colitis mice were then treated with ONO-5046 (50 mg/kg body weight) intraperitoneally twice a day. Results: In UC patients, the NE enzyme activity was significantly elevated in both the plasma and colonic mucosal tissue compared with healthy controls. In DSS-induced colitis mice, the NE enzyme activity increased in parallel with the disease development. ONO-5046 showed therapeutic effects in DSS-treated mice by significantly reducing weight loss and histological score. ONO-5046 suppressed the NE enzyme activities in both plasma and culture supernatant of colonic mucosa from DSS-induced colitis mice. Conclusions: ONO-5046, a specific NE inhibitor, prevented the development of DSS-induced colitis in mice. NE therefore represents a promising target for the treatment of UC patients.

AB - Background: Neutrophil elastase (NE) is a major secretory product from activated neutrophils and a major contributor to tissue destruction. However, little is known about the pathogenic contribution of NE to ulcerative colitis (UC). This study was designed to investigate the contribution of NE by measuring NE activity in plasma and colonic mucosal tissue from UC patients and a murine acute colitis model, and to elucidate the therapeutic effect of the NE-specific inhibitor ONO-5046. Methods: The NE enzyme activities in plasma and colonic mucosal tissue from UC patients were directly measured using an enzyme-substrate reaction. Acute colitis was induced in mice by administration of 1.5% dextran sulfate sodium (DSS) for 5 days. DSS-induced colitis mice were then treated with ONO-5046 (50 mg/kg body weight) intraperitoneally twice a day. Results: In UC patients, the NE enzyme activity was significantly elevated in both the plasma and colonic mucosal tissue compared with healthy controls. In DSS-induced colitis mice, the NE enzyme activity increased in parallel with the disease development. ONO-5046 showed therapeutic effects in DSS-treated mice by significantly reducing weight loss and histological score. ONO-5046 suppressed the NE enzyme activities in both plasma and culture supernatant of colonic mucosa from DSS-induced colitis mice. Conclusions: ONO-5046, a specific NE inhibitor, prevented the development of DSS-induced colitis in mice. NE therefore represents a promising target for the treatment of UC patients.

KW - Dextran sulfate sodium-induced colitis

KW - Neutrophil elastase

KW - ONO-5046

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=33744806687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744806687&partnerID=8YFLogxK

U2 - 10.1007/s00535-005-1768-8

DO - 10.1007/s00535-005-1768-8

M3 - Article

C2 - 16741610

AN - SCOPUS:33744806687

VL - 41

SP - 318

EP - 324

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 4

ER -